???pagination.result.count???
???pagination.result.page???
1
Kaitocephalin antagonism of glutamate receptors expressed in Xenopus oocytes. , Limon A., ACS Chem Neurosci. March 17, 2010; 1 (3): 175-181.
Absence of antibodies to glutamate receptor type 3 ( GluR3) in Rasmussen encephalitis. , Watson R., Neurology. July 13, 2004; 63 (1): 43-50.
Glutamate receptor subunit 3 is modified by site-specific limited proteolysis including cleavage by gamma-secretase. , Meyer EL., J Biol Chem. June 27, 2003; 278 (26): 23786-96.
In-vitro and in-vivo action of cannabinoids. , Akinshola BE., Neurochem Res. October 1, 1999; 24 (10): 1233-40.
Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA. , Stensbøl TB., Eur J Pharmacol. September 10, 1999; 380 (2-3): 153-62.
Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. , Akinshola BE., Naunyn Schmiedebergs Arch Pharmacol. September 1, 1999; 360 (3): 242-8.
Resolution, absolute stereochemistry, and enantiopharmacology of the GluR1-4 and GluR5 antagonist 2-amino-3-[5- tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid. , Møller EH., Chirality. January 1, 1999; 11 (10): 752-9.
Molecular and electrophysiological characterizations of fGluR3 alpha, an ionotropic glutamate receptor subunit of a teleost fish. , Chang HM., Brain Res Mol Brain Res. June 15, 1998; 57 (2): 211-20.
Pharmacological differentiation between neuronal and recombinant glutamate receptor channels expressed in Xenopus oocytes. , Blaschke M., Neuropharmacology. January 1, 1997; 36 (11-12): 1489-501.
CDNA cloning of chick brain alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors reveals conservation of structure, function and post-transcriptional processes with mammalian receptors. , Paperna T., Brain Res Mol Brain Res. February 1, 1996; 36 (1): 101-13.